New classification improves risk prediction in chronic lymphocytic leukemia
If chronic lymphocytic leukemia patients with a good or poor prognosis could be identified already at the time of diagnosis, physicians would have better possibilities to adjust their therapeutic and follow-up strategies. Now researchers at Uppsala University have discovered a new correlation between specific molecular features of the disease and subgroups of patients with different prognosis.